B of A Securities Rates Definitive Healthcare (DH) sell

B of A Securities has lowered its rating on DH to sell with a price target of $0.70, a 2.51% downside from the current price.

By EarningsIQ Research Desk · Published Jun 29, 2026, 8:02 AM EDT · Updated Jul 1, 2026, 2:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

B of A Securities rated Definitive Healthcare Corp. ($DH) "sell" with a $0.70 price target on June 29, 2026.

Since the rating, $DH is up 19.4% after 1 week, up 1.4% after 1 month and up 38.9% to date (from the $0.72 close on Jun 29, 2026).

DH Definitive Healthcare Corp.

$1 -57.98% year to date

Daily close · Oct 16, 2026

Key Points

B of A Securities downgraded DH to a sell rating with a $0.70 target on June 29, 2026.
B of A Securities's $0.70 price target implies 2.51% downside from Definitive Healthcare Corp.'s ($DH) current $0.72 share price.
Shares of DH traded near $0.66 on Monday, reflecting the recent analyst action.
Insiders at DH have been active, with several purchases and sales in early June.

Get $DH trade alerts by text

We text you when insiders, Congress or big funds trade $DH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Definitive Healthcare Corp. alert may contain errors. Disclosures

B of A Securities has downgraded its rating on DH to a sell, setting a price target of $0.70. The downgrade, announced on June 29, 2026, reflects a cautious outlook on the company's prospects.

Analyst rating track record

B of A Securities vs. the S&P 500

YTD return +4.74% hypothetical

All-time return +28.26% S&P 500 +23.59%

vs. S&P 500 +4.67% ahead of the index

Hypothetical returns from B of A Securities's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in DH

In recent institutional moves, Advent International, L.P. maintained its position with 62.5 million shares valued at approximately $76.9 million. Goldman Sachs Group Inc increased its holdings by 101,949 shares, resulting in a total of about 6 million shares worth $7.4 million, marking a 1.7% increase. BlackRock, Inc. also grew its stake by 80,879 shares to hold nearly 3 million shares valued at $3.7 million, a 2.8% rise. Meanwhile, Dimensional Fund Advisors LP reduced its holdings by 251,434 shares, ending with about 1.7 million shares valued at $2 million, a 13.1% decrease.

Definitive Healthcare Corp. Stock Down 25.2%

Shares of DH traded near $0.66 on Monday. The stock has been under scrutiny following the recent analyst downgrade.

12-month forecast

$DH price target

Definitive Healthcare Corp. daily closes and this analyst's $0.70 target. Not advice.

Insider Buying and Selling at Definitive Healthcare Corp.

Insider activity at DH has been notable. On June 4, 2026, Hamood Samuel, Kathleen Winters, Scott Stephenson, and Chilukuri Sastry each bought 189,190 shares. Earlier, on June 1, 2026, CEO Kevin Coop sold 66,050 shares at an average price of $0.99, while CFO Casey Heller sold 164,377 shares at the same price.

Analysts Set New Price Targets

On June 29, 2026, B of A Securities downgraded DH to a sell rating with a $0.70 price target. Barclays maintained its sell rating with a $1.00 target on March 30, 2026. Canaccord Genuity and Stephens & Co. have both maintained hold ratings with targets of $3.00 and $2.00, respectively, earlier in the year.

Bottom Line

The recent downgrade by B of A Securities to a sell rating with a $0.70 target adds pressure on DH, which is already trading at low levels. Investors will be watching closely to see how the company responds to these challenges. The activity of insiders and institutional investors provides additional context to the market's view on DH.